Dilpacimab

Tax included
Dilpacimab (ABT165) is a potent dual-variable domain immunoglobulin, targets both delta-like ligand 4 (DLL4) and VEGF pathways.. Dilpacimab can be used in research of cancer.
MedChemExpress 
HY-P99852

Data sheet

Size
Multiple sizes
Reactivity
VEGFR
CAS
1791420-09-1